Stock Split Watch: Lilly — Is Eli Lilly Next to Split?
Eli Lilly has been a standout growth stock thanks to GLP-1 drug demand. Could a stock split be on the horizon? This g...
Post-mistake savings require quick wins and steady progress: cut nonessential costs, automate savings, and reassess your priorities.
21,607 articlesEli Lilly has been a standout growth stock thanks to GLP-1 drug demand. Could a stock split be on the horizon? This g...
A senior executive recently reduced his stake in CATY by one third through an open market sale. This article explains...
In a move seen across aging portfolios, a 62-year-old couple bought $480,000 policy to substitute for taxable bonds, ...
A biotech stock that surged 700% remains a cornerstone of many portfolios even after a sizable last-quarter sale by a...
A clear, actionable preview of ABM's Q2 2026 results. Learn what the (abm) 2026 earnings call could reveal about reve...
A mid‑sized fund just boosted its stake in ServiceTitan after a sharp share drop. This article unpacks what the move ...
When volatility strikes in crypto markets, savvy treasury moves can reshape investor value. This piece examines how a...
Stacey King helped the Bulls build a dynasty and later became a trusted voice for fans. This tribute isn’t just about...
A broad market rally lifted major indexes on Feb. 24 as traders anticipated Nvidia’s earnings and awaited remarks fro...
A surprising analyst upgrade helped StubHub Holdings stock crush expectations this week. This article breaks down the...
When a CEO discloses a large stock sale, markets react. This guide breaks down what sells $2.4 million international ...
When an investment firm Absoluto Partners reveals a fresh stake in MercadoLibre, traders take note. This in-depth gui...